ARCHIVES

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

This article is from The Cancer Letter archive.

Vol. 22 No. 21 | May 24, 1996

Download PDF Visit The Full Archive

Related Articles

Advocates Oppose Proposals to Market Drugs After Phase I.

June 9, 2006

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

March 28, 2008

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011